ID
24570
Descripción
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Palabras clave
Versiones (1)
- 6/8/17 6/8/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
6 de agosto de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Descripción
If "yes" to COPD exacerbation, record following items.
Alias
- UMLS CUI-1
- C0740304
Descripción
date of onset of COPD exacerbation
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C0740304
Descripción
outcome of COPD exacerbation
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0085565
- UMLS CUI [1,2]
- C0740304
Descripción
date of resolution or death
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2985858
- UMLS CUI [2]
- C1148348
Descripción
severity of COPD excerbation
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0439793
- UMLS CUI [1,2]
- C0740304
Descripción
Subjects who experience more than one moderate exacerbation requiring antibiotic and/or oral corticosteroid treatment during the treatment period and/or experience a severe exacerbation requiring hospitalisation during the course of the study must be withdrawn.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0740304
Similar models
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
C0740304 (UMLS CUI [1,2])
C0740304 (UMLS CUI [1,2])
C1148348 (UMLS CUI [2])
C0740304 (UMLS CUI [1,2])
C0740304 (UMLS CUI [1,2])